Steven Stanton

Senior Scientist in Oligonucleotide Process Chemistry at AstraZeneca

Speaker

Dr Steven Stanton joined AstraZeneca in 2021 as a Senior Scientist in Process Chemistry at the Macclesfield site in the UK. Since then he has focussed on the optimisation of solid-phase oligonucleotide synthesis for AstraZeneca's late stage oligonucleotide platform including through the application of PAT technologies. Prior to AstraZeneca, Steven obtained his PhD in small molecule organic chemistry from the University of Bristol in the UK, and carried out a post-doc in mRNA delivery materials at Stanford University, USA.